GAGGVGKSA

GAGGVGKSA is a wild type KRAS G12D 9mer peptide. GAGGVGKSA can be used as an immunogenic neoantigen for cancer immunotherapy research[1].

Others

Peptides

Others

COVID-19-immunoregulation

Cancer; Inflammation/Immunology

https://www.medchemexpress.com/gaggvgksa.html

10 mM in DMSO

OC([C@H](C)NC([C@H](CO)NC([C@H](CCCCN)NC(CNC([C@H](C(C)C)NC(CNC(CNC([C@H](C)NC(CN)=O)=O)=O)=O)=O)=O)=O)=O)=O

702.76

[1]Bai P, et al. Characters of neoantigens in cancer immunotherapy. bioRxiv, 2019: 700732.

Room temperature

http://file.medchemexpress.com/batch_PDF/HY-P3487/GAGGVGKSA-DataSheet-MedChemExpress.pdf

http://file.medchemexpress.com/batch_PDF/HY-P3487/

No Development Reported

1223335-84-9